
Immunovant Inc (IMVT)
Order type
Buy in
Order amount
Est. shares
0 shares
Buy Immunovant Inc (IMVT) Stock
Start investing in Immunovant Inc (IMVT)
About Immunovant Inc (IMVT)
Market cap | $2.68B |
Today's volume | 1.09M |
Revenue (TTM) | — |
Avg. daily volume | 1.78M |
EBITDA (TTM) | -$437.78M |
Open | $15.67 |
Price / earnings ratio | -5.72x |
Today's range | $15.35 - $16.08 |
Debt / equity | 0.01x |
52 week range | $12.72 - $34.47 |
5 year debt / equity | 0.17x |
Beta (LTM) | 1.14x |
Interest coverage | — |
Dividend & yield | $0.00 (0.00%) |
Current ratio | 11.16x |
Ex-dividend date | — |
Next earnings | Aug 5, 2025 |
Dividend payable date | — |
Immunovant Inc Stock Rating
Immunovant Inc Stock News
View all



Frequently Asked Questions (FAQ)
How to buy IMVT stock on Public
- 1
Sign up for a brokerage account on Public
It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.
- 2
Add funds to your Public account
There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.
- 3
Choose how much you'd like to invest in IMVT stock
Navigate to the Explore page. Then, type IMVT into the search bar. When you see IMVT stock appear in the results, tap it to open up the purchase screen.
- 4
Manage your investments in one place
You can find your newly purchased IMVT stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.
Immunovant Inc Stock Earnings
The value each IMVT share was expected to gain vs. the value that each IMVT share actually gained.
Immunovant Inc (IMVT) reported Q4 2025 earnings per share (EPS) of -$0.64, beating estimates of -$0.72 by 11.11%. In the same quarter last year, Immunovant Inc's earnings per share (EPS) was -$0.52. Immunovant Inc is expected to release next earnings on 08/05/2025, with an earnings per share (EPS) estimate of $0.